How did this first-of-its-kind platform trial tackle ALS's debilitating disease progression and what can other rare disease study teams learn from it?
Firma's Dr. D.J. Tang shares in a Clinical Researcher article insights on effective data analysis for nontraditional study designs.
More and more global clinical trials are using a hybrid approach to study visits. Find out the biggest challenges--and how to solve them.
What sites and study teams really want to know about using remote, in-home visits as part of their clinical trial protocols. The answers to the most common questions.
Nikki Skirvin was interviewed by Jenni Spinner about multi-national studies in an article for Outsourcing Pharma earlier this year.
In a recent study, researchers looked at two randomized comparative trials evaluating COVID-19 treatments and outlined the problematic gaps created by the use of the Kaplan-Meier method and hazard ratio.
Firma’s Dr. D.J. Tang shares in an Outsourcing-Pharma article why RWD can be useful in drug research and development.
Firma Clinical recently commenced a Scientific Advisory Board for its clinical services, including biometrics/data.
In Outsourcing-Pharma, Melissa Nezos, explains how the pandemic increased the need to bring the study to the patient.
Firma’s Melissa Nezos shares in an Applied Clinical Trials article the important role of home visits in hybrid and decentralized/virtual clinical trials.